<DOC>
	<DOCNO>NCT00702117</DOCNO>
	<brief_summary>The study evaluate 3 different population : It open , randomize , parallel-group study compare effectiveness intravenous ( iv ) ajmaline currently use antiarrhythmic drug acute treatment : 1. recent-onset atrial fibrillation versus iv flecainide 2. sustain monomorphous ventricular tachycardia versus iv procainamide The study also evaluate open , randomize , crossover study , use iv ajmaline versus iv flecainide diagnosis Brugada syndrome</brief_summary>
	<brief_title>Ajmaline Utilization Diagnosis Treatment Cardiac Arrhythmias</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<mesh_term>Brugada Syndrome</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<mesh_term>Flecainide</mesh_term>
	<mesh_term>Ajmaline</mesh_term>
	<mesh_term>Lorajmine</mesh_term>
	<mesh_term>Procainamide</mesh_term>
	<criteria>AF : Patients isolate , idiopathic , sustain , symptomatic , recent onset ( &gt; 10 minute &lt; 24 hour ) atrial fibrillation . VT : Patients ventricular tachycardia good haemodynamic tolerability attend emergency room induce electrophysiology lab test ventricular arrhythmia . Brugada Sd ( BrS ) : Firstdegree relative patient Brugada Syndrome ECG nondiagnostic BrS . General : Pregnancy AF : Preexisting heart disease . Secondary AF 2nd 3rd degree AV block RBBB associate LAFB LPFB ( bifascicular block ) . LVF &lt; 40 % . Moderatesevere liver failure . AF haemodynamic compromise . VT : VT haemodynamic compromise . BrS : Preexisting heart disease . 2nd 3rd degree AV block RBBB associate LAFB LPFB ( bifascicular block ) . Moderatesevere liver failure .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>